Wendy Gill
Adult Health · Baton Rouge, LANPI 1821272709
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,172 of the $12,542 with a category attached, or 89.1%. It is spread thinly across 60 manufacturers, the largest accounting for just 9.8% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 583 payments — averaging $21.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Novartis$1K
- AstraZeneca$960
- Pfizer$856
- Merck$499
- Takeda Pharmaceuticals U.S.A., Inc.$490
- plus $7K from 54 others
What the payments were for
- Food & beverage$11,17289%
- Education$1,37011%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,542 in reported general payments places this provider in the 95th percentile of 203 adult health providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mirtazapine | 34 | $630 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 36 | $627 |
| Anastrozole | 37 | $522 |
| Ondansetron Hcl | 65 | $503 |
| Sucralfate | 12 | $432 |
| Gabapentin | 36 | $334 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 23 | $317 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $308 |
| Dexamethasone | 29 | $280 |
| Hydrocortisone | 13 | $271 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $266 |
| Prednisone | 55 | $243 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 16 | $239 |
| Prochlorperazine Maleate | 24 | $206 |
| Ondansetron OdtOndansetron | 12 | $172 |
Paid to pharmacies, not to this prescriber.
Other adult health in Baton Rouge
- Joan SmithBaton Rouge$121K
- Deborah SmithBaton Rouge$18K
- Tanisha SmithBaton Rouge$17K
- Eva Marina StaffordBaton Rouge$15K
- Dustin DenicolaBaton Rouge$14K
- Jennifer LeblancBaton Rouge$12K
- Carrie PerryBaton Rouge$6K
- Auldyn HirscheyBaton Rouge$6K
- Colette BlanchardBaton Rouge$6K
- Stephanie AkunneBaton Rouge$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.